Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: A cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients

Joint Bone Spine

Volumn 79, Issue 1, 2012, Pages 57-62

  Bossert, Marie ^a   Prati, Clément ^a   Vidal, Chrystelle ^b   Bongain, Séverine ^b   Toussirot, Éric ^a   Wendling, Daniel ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b HÔPITAL SAINT JACQUES   (France)

Author keywords

Flare; RADAI5; RAPID3; Rheumatoid arthritis; Self report

Indexed keywords

ADULT; ARTICLE; CLINICAL DISEASE ACTIVITY INDEX; COMPARATIVE STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE 28; DISEASE DURATION; DISEASE EXACERBATION; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RATING SCALE; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS DISEASE ACTIVITY INDEX 5; ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3; SELF REPORT; SENSITIVITY AND SPECIFICITY; SIMPLIFIED DISEASE ACTIVITY INDEX; VALIDITY;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DIAGNOSTIC SELF EVALUATION; DRUG THERAPY, COMBINATION; HEALTH STATUS; HUMANS; MIDDLE AGED; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; ROC CURVE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84855713724     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.03.014     Document Type: Article

References (41)

1. Haute Autorité de santé Polyarthrite rhumatoïde: diagnostic et prise en charge initiale. Recommandations; septembre 2007.
2. Smolen J.S., Landewé R., Breedveld F.C. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69:964-975.
3. Smolen J.S., Aletaha D. Activity assessments in rheumatoid arthritis. Curr Opin Rheumatol 2008, 20:306-313.
4. Felson D.T., Anderson J.J., Boers M., et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993, 36:729-740.
5. Aletaha D., Landewe R., Karonitsch T., et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008, 67:1360-1364.
6. Van der Heijde D.M., van't Hof M.A., van Riel P.L., et al. Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis 1992, 51:177-181.
7. Pincus T., Sokka T. Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol 2005, 23:1-9.
8. Prevoo M.L.L., van't Hof M.A., Kuper H.H., et al. Disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
9. Pincus T. The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis. J Rheumatol 2006, 33:834-837.
10. Pincus T., Segurado O.G. Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 2006, 6:820-822.
11. Smolen J.S., Breedveld F.C., Shiff H., et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003, 42:244-257.
12. Aletaha D., Nell V.P., Stamm T., et al. Acute-phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005, 7:R796-R806.
13. Dougados M, Nataf H, Steinberg G, et al. Relative importance of subjective (patient's perspective) and objective (physician's perspective) information for the treatment decision in rheumatoid arthritis: the duo study [abstract]. SAT0480.
14. Kalyoncu U., Dougados M., Daurès J.P., et al. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009, 68:183-190.
15. Pincus T., Keysor J., Sokka T., et al. Patient questionnaires and formal education level as prospective predictors of mortality over 10years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol 2004, 31:229-234.
16. Wolfe F., Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999, 42:1797-1808.
17. Pincus T. The American College of Rheumatology (ACR) Core Data Set and derivative " patient only" indices to assess rheumatoid arthritis. Clin Exp Rheumatol 2005, 23:109-113.
18. Pincus T., Sokka T. Quantitative clinical assessment in busy rheumatology settings: the value of short patient questionnaires. J Rheumatol 2008, 35:1235-1237.
19. Yazici Y., Bergman M., Pincus T. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol 2008, 35:603-609.
20. Pincus T., Bergman M.J., Yazici Y., et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 2008, 47:345-349.
21. Pincus T., Swearingen C.J., Bergman M., et al. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol 2008, 35:2136-2147.
22. Pincus T., Swearingen J.C., Bergman M.J., et al. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories. Scored in five versus more than ninety seconds. Arthritis Care Res 2010, 62:181-189.
23. Leeb B.F., Haindl P.M., Maktari A., et al. Patient-centered rheumatoid arthritis disease activity assessment by a modified RADAI. J Rheumatol 2008, 35:1294-1299.
24. Leeb B.F., Sautner J., Mai H.T., et al. A comparison of patient questionnaires and composite indexes in routine care of rheumatoid arthritis patients. Joint Bone Spine 2009, 76:658-664.
25. Sokka T., Hetland M.L., Mäkinen H., et al. Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008, 58:2642-2651.
26. Shaver T.S., Anderson J.D., Weidensaul D.N., et al. The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 2008, 35:1015-1022.
27. Bingham C.O., Pohl C., Woodworth T.G., et al. Developing a standardized definition for disease " flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol 2009, 36:2235-2241.
28. Pincus T., Bergman M.J., Yazici Y. RAPID3-an index of physical function, pain, and global status as " vital signs" to improve care for people with chronic rheumatic diseases. Bull NYU Hosp Jt Dis 2009, 67:211-225.
29. Aletaha D., Neogi T., Silman A.J., et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Agains Rheumatism collaborative initiative. Ann Rheum Dis 2010, 69:1580-1588.
30. Pincus T., Chung C., Segurado O.G., et al. An index of patient-reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 2006, 33:2146-2152.
31. Pincus T., Strand V., Koch G., et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003, 48:625-630.
32. Cohen S.B., Strand V., Aguilar D., et al. Patient-versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology (Oxford) 2004, 43:704-711.
33. Strand V., Cohen S., Crawford B., et al. Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:640-647.
34. Pincus T., Yazici Y., Bergman M., et al. A proposed approach to recognise " near-remission" quantitatively without formal joint counts or laboratory tests: a patient self-report questionnaire routine assessment of patient index data (RAPID) score as a guide to a " continuous quality improvement" Clin Exp Rheumatol 2006, 24:60-73.
35. Rintelen B., Haindl P.M., Sautner J., et al. The rheumatoid arthritis disease activity index-5 in daily use. Proposal for disease activity categories. J Rheumatol 2009, 36:918-924.
36. Heiberg T., Kvien T.K., Mowinckel P., et al. Identification of disease activity and health status cutoff points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis 2008, 67:967-971.
37. Leeb B.F., Andel I., Leder S., et al. The patient's perspective and rheumatoid arthritis disease activity indexes. Rheumatology (Oxford) 2005, 44:360-365.
38. Welsing P.M., Landewé R.B., van Riel P.L., et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004, 50:2082-2093.
39. Leeb B.F., Sautner J., Leeb B.A., et al. Lack of agreement between patients' and physicians' perspectives of rheumatoid arthritis disease activity changes. Scand J Rheumatol 2006, 35:441-446.
40. Berthelot J.M., Blanchais A., Marhadour T., et al. Fluctuations in disease activity scores for inflammatory joint disease in clinical practice: do we need a solution?. Joint Bone Spine 2009, 76:126-128.
41. Blanchais A., Berthelot J.M., Fontenoy A.M., et al. Weekly home self-assessment of RAPID3-4 scores in rheumatoid arthritis: a 6-month study in 26 patients. Joint Bone Spine 2010, 77:582-587.